ALTO-300 in Depression
Public ClinicalTrials.gov record NCT05118750. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label Study of ALTO-300 in Adults With Major Depressive Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to collect biologically-based data for defining predictors and correlates of the effects of ALTO-300.
Study identification
- NCT ID
- NCT05118750
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 91 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 74 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 12, 2021
- Primary completion
- May 4, 2023
- Completion
- May 8, 2023
- Last update posted
- Apr 29, 2024
2021 – 2023
United States locations
- U.S. sites
- 11
- U.S. states
- 6
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 153 | Culver City | California | 90230 | — |
| Site 103 | Sacramento | California | 95757 | — |
| Site 158 | Santee | California | 92071 | — |
| Site 159 | Clermont | Florida | 34711 | — |
| Site 161 | Okeechobee | Florida | 34972 | — |
| Site 137 | Noblesville | Indiana | 46060 | — |
| Site 166 | Saint Charles | Missouri | 63304 | — |
| Site 132 | New York | New York | 10023 | — |
| Site 102 | Dallas | Texas | 75235 | — |
| Site 165 | DeSoto | Texas | 75115 | — |
| Site 147 | Fort Worth | Texas | 76104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05118750, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 29, 2024 · Synced Sep 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05118750 live on ClinicalTrials.gov.